EnerSpar Corp. (TSE:NRX) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
NurExone Biologic Inc. has announced a significant stride in regenerative medicine by partnering with a German GMP manufacturer for the production of their ExoPTEN nanodrug’s active siRNA element. This collaboration is set to meet the high-quality standards necessary for clinical trials and potential commercialization. The new GMP-manufactured siRNA has demonstrated comparable effectiveness in reducing PTEN expression, crucial for nerve regeneration therapies.
For further insights into TSE:NRX stock, check out TipRanks’ Stock Analysis page.
